Market Research Report
North America Orthopedic Biomaterials Market (2019-2025)
|Published by||KBV Research||Product code||914161|
|Published||Content info||65 Pages
Delivery time: 1-2 business days
|North America Orthopedic Biomaterials Market (2019-2025)|
|Published: September 30, 2019||Content info: 65 Pages||
The North America Orthopedic Biomaterials Market would witness market growth of 9.65% CAGR during the forecast period (2019-2025). The prevailing market in North America in 2018 is expected to continue to grow over the forecast period at a profitable growth. This growth may be linked to the increase in the number of knee replacement, reconstruction, and other orthopedic procedures associated with the joint. The rapid adoption of advanced products for filling the bone void and implant load-bearing is expected to further boost the global industry.
The main consideration before the use of Orthopedic Biomaterials in orthopedic applications is the biocompatibility of the material. Other attributes over which the success of biomaterials in biological applications relies on is the choice of material for its development, suitable specifications, stability and multiple characteristics such as durability and compressive strength as well as their interaction with hard and soft tissues and intra and extracellular fluids of the human body and blood.
Based on Material Type, the market is segmented into Emergency Care, Short-Term Stabilization, Trauma Care, Acute care surgery and Other Conditions. Based on Application, the market is segmented into Orthopedic Implants, Joint Replacements, Bio-resorbable Tissue Fixation, Orthobiologics and Visco Supplementation. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical, Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech, Inc., Collagen Matrix, Inc., Evonik Industries AG and Koninklijke DSM N.V. (DSM Biomedical B.V.).